Connect with us
Immuno-oncology and molecular oncology are two of Sanofi's most promising bets to tackle some of the most difficult-to-treat cancers. While immuno-oncology research is focused on finding...
The Liège-based biotech company PDC*line Pharma, which specializes in immuno-oncology, has initiated a Phase I/II study to evaluate a therapeutic vaccine against lung cancer. This cancer...
A new combination of drugs has brought good news for both ovarian and lung cancer patients.
The anti-smoking advocacy groups score a victory as tobacco companies are now mandated to disclose the dangers of smoking to the public.
Different studies link the use of talc-based products to ovarian cancers. However, results vary and are often inconclusive.